The latest research shows that Gps can improve mouse depression-like behavior by modulating neuroinflammatory pathways, including the hippocampal NF-κB pathway (Dong et al., 2018) and the BDNF-ERK/Akt signaling pathway (Mu et al., 2016). Here, NFKB1 is linked to depressive symptom measurement.